Su Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Su Gao has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Ellen E. Ladenheim
Psychiatry and Behavioral Sciences, and
1 shared publicationGabriele V. Ronnett
Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205
1 shared publicationGary D. Lopaschuk
Department of Pediatrics, 423 Heritage Medical Research Center, University of Alberta, Edmonton, AB, Canada T6G 2S2
1 shared publication- Karen A. Scott
Neuroscience Institute, College of Arts and Sciences (K.E., M.K.K., D.N.J., C.J.V., K.A.S., J.E.S., A.D.d.K., E.G.K.), Georgia State University, Atlanta
1 shared publication Kellie L. K. Tamashiro
Psychiatry and Behavioral Sciences, and
1 shared publicationKen Strynadka
Department of Pediatrics, 423 Heritage Medical Research Center, University of Alberta, Edmonton, AB, Canada T6G 2S2
1 shared publication
Latest Publications
- Open Access
- 30 October 2007
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (44) , 17358-17363
Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake
Hypothalamic fatty acid metabolism has recently been implicated in the controls of food intake and energy homeostasis. We report that intracerebroventricular (ICV) injection of leptin, concomitant with inhibiting AMP-activated kinase (AMPK), activates acetyl-CoA carboxylase (ACC), the key regulatory enzyme in fatty acid biosynthesis, in the arcuate nucleus (Arc) and paraventricular nucleus (PVN) in the hypothalamus. Arc overexpression of constitutively active AMPK prevents the Arc ACC activation in response to ICV leptin, supporting the hypothesis that AMPK lies upstream of ACC in leptin's Arc intracellular signaling pathway. Inhibiting hypothalamic ACC with 5-tetradecyloxy-2-furoic acid, a specific ACC inhibitor, blocks leptin-mediated decreases in food intake, body weight, and mRNA level of the orexigenic neuropeptide NPY. These results show that hypothalamic ACC activation makes an important contribution to leptin's anorectic effects. Furthermore, we find that ICV leptin up-regulates the level of malonyl-CoA (the intermediate of fatty acid biosynthesis) specifically in the Arc and increases the level of palmitoyl-CoA (a major product of fatty acid biosynthesis) specifically in the PVN. The rises of both levels are blocked by 5-tetradecyloxy-2-furoic acid along with the blockade of leptin-mediated hypophagia. These data suggest malonyl-CoA as a downstream mediator of ACC in leptin's signaling pathway in the Arc and imply that palmitoyl-CoA, instead of malonyl-CoA, could be an effector in relaying ACC signaling in the PVN. Together, these findings highlight site-specific impacts of hypothalamic ACC activation in leptin's anorectic signaling cascade.
- 30 October 2007
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (44) , 17358-17363
Open AccessLeptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake
Hypothalamic fatty acid metabolism has recently been implicated in the controls of food intake and energy homeostasis. We report that intracerebroventricular (ICV) injection of leptin, concomitant with inhibiting AMP-activated kinase (AMPK), activates acetyl-CoA carboxylase (ACC), the key regulatory enzyme in fatty acid biosynthesis, in the arcuate nucleus (Arc) and paraventricular nucleus (PVN) in the hypothalamus. Arc overexpression of constitutively active AMPK prevents the Arc ACC activation in response to ICV leptin, supporting the hypothesis that AMPK lies upstream of ACC in leptin's Arc intracellular signaling pathway. Inhibiting hypothalamic ACC with 5-tetradecyloxy-2-furoic acid, a specific ACC inhibitor, blocks leptin-mediated decreases in food intake, body weight, and mRNA level of the orexigenic neuropeptide NPY. These results show that hypothalamic ACC activation makes an important contribution to leptin's anorectic effects. Furthermore, we find that ICV leptin up-regulates the level of malonyl-CoA (the intermediate of fatty acid biosynthesis) specifically in the Arc and increases the level of palmitoyl-CoA (a major product of fatty acid biosynthesis) specifically in the PVN. The rises of both levels are blocked by 5-tetradecyloxy-2-furoic acid along with the blockade of leptin-mediated hypophagia. These data suggest malonyl-CoA as a downstream mediator of ACC in leptin's signaling pathway in the Arc and imply that palmitoyl-CoA, instead of malonyl-CoA, could be an effector in relaying ACC signaling in the PVN. Together, these findings highlight site-specific impacts of hypothalamic ACC activation in leptin's anorectic signaling cascade.